Group 1 - Aurora Spine Corporation will participate in the 38th Annual ROTH Conference from March 22-24, 2026, hosted by Roth Capital Partners [1] - The conference will take place at the Ritz-Carlton in Laguna Niguel, California, and the management team will be available for one-on-one meetings with investors [1] - Investors interested in scheduling a meeting can contact their Roth representative or email the company directly [2] Group 2 - The Annual ROTH Conference is one of the largest in the nation for small-cap companies, featuring company presentations, Q&A sessions, and management one-on-one meetings [3] - Approximately 500 private and public companies from various growth sectors will be represented at the conference [3] - Roth's Research Team identifies distinguished presenting companies across sectors including consumer, energy, healthcare, and technology [3] Group 3 - Aurora Spine is an innovative designer and manufacturer of minimally invasive spinal implants and interventional pain management technologies [4] - The company's mission is to improve spinal surgery outcomes through simplified, integrated, and cost-effective solutions that advance patient care worldwide [4]

Core Viewpoint - Aurora Spine Corporation has amended an existing loan agreement, reducing the interest rate and extending the maturity date, which reflects the company's ongoing financial management strategy [1][2]. Loan Details - The principal amount of the loan is US$1,600,000, with accrued and unpaid interest totaling US$1,249,500 [1]. - The interest rate has been reduced from 9% to 4.5% per annum effective January 1, 2026 [2]. - The maturity date has been extended from June 29, 2027, to July 11, 2029 [2]. - In the event of a default, the interest rate will increase to 12% per annum [2]. Related Party Transaction - The loan is classified as a "related party transaction" under Multilateral Instrument 61-101, but is exempt from formal valuation and minority approval requirements [3]. - The company was unable to file a material change report more than twenty-one days prior to the loan completion [3]. Company Overview - Aurora Spine Corporation is based in Carlsbad, California, and specializes in designing and manufacturing minimally invasive spinal implants and interventional pain management technologies [5]. - The company's mission is to enhance spinal surgery outcomes through integrated and cost-effective solutions [5].

Core Viewpoint - Aurora Spine Corporation has amended an existing loan agreement, reducing the interest rate and extending the maturity date, which reflects the company's ongoing financial management strategy [1][2]. Loan Details - The principal amount of the loan is US$1,600,000, with accrued and unpaid interest totaling US$1,249,500 [1]. - The interest rate has been reduced from 9% to 4.5% per annum effective January 1, 2026 [2]. - The maturity date has been extended from June 29, 2027, to July 11, 2029 [2]. - In the event of a default, the interest rate will increase to 12% per annum [2]. - The company can prepay the loan without penalty [2]. Related Party Transaction - The loan is classified as a "related party transaction" under Multilateral Instrument 61-101 but is exempt from formal valuation and minority approval requirements [3]. - The company was unable to file a material change report more than twenty-one days prior to the loan completion [3]. Conditions and Approvals - The loan is subject to certain conditions, including the receipt of necessary approvals [4].